arrow
T

Tao Cai

school of sports medicine and health
H指数:45
被引数:7,444

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and Safety of Stapokibart in Adults With Moderate-to-Severe Atopic Dermatitis With and Without Type 2 Comorbidities: A Post Hoc Analysis of a Phase 3 Trial

司妥昔单抗(Stapokibart)在伴有或不伴有2型合并症的成人中重度特应性皮炎中的有效性与安全性:一项基于III期试验的回顾性分析

2025-11-190
OAAI
Efficacy and Safety of Anti-IL-4Rα Stapokibart in Elderly Patients With Moderate-To-Severe Atopic Dermatitis

抗IL-4Rα单抗stapokibart在老年中重度特应性皮炎患者中的有效性与安全性

2025-11-010
OAAI
Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis Treated with Stapokibart over 52 weeks: A Post Hoc Analysis of a Phase 3 Trial

中度至重度特应性皮炎成人患者使用Stapokibart治疗52周后的患者报告结局:一项III期临床试验的事后分析

2025-07-120
PRE
Long-Term Stapokibart Treatment Induces Sustained Clinical Improvements in Patients With Moderate-to-Severe Atopic Dermatitis
2025-03-010
PRE
Long-term efficacy and safety of stapokibart for moderate-to-severe atopic dermatitis: 52-week results from a phase 3 trial

stapokibart治疗中重度特应性皮炎的长期疗效和安全性: 一项3期试验的52周结果

2024-10-250
PRE